Wasn’t it about a month ago that I was carrying on about howI felt disrespected? Wasn’t it just a week or two ago that I said that life is good and... More »
The incidence of metabolic syndrome is rapidly increasing. Metabolic syndrome is associated with elevated morbidity and mortality secondary to... More »
Plasmacytoma is a rare B-lymphocyte neoplastic disorder that usually presents as the generalized disease multiple myeloma. Less than 5% of the cases... More »
A 71-year-old African American man presented to the emergency department (ED) with chest pain, dyspnea, and hemoptysis. He had had a few ED visits for... More »
A 36-year-old woman presented to the emergency department with loss of vision in the right eye that had initially involved the peripheral field and... More »
What ever happened to manners? To courtesy? Why do patients feel that our time is unimportant? That we should just sit there and take it when they... More »
I don’t expect primary-care physicians and other subspecialists to know all the nuances of diagnosing and treating endocrine disorders. After all,... More »
“Drug rash” is a common pediatric complaint in both inpatient and outpatient settings. This term, however, denotes a clinical category and is not a... More »
Multiple novel therapies primarily targeting angiogenesis have entered clinical trials for metastatic thyroidcarcinoma. Partial response rates up to 30% have been ...cancer. Treatment for patients with metastatic or advanced thyroidcarcinoma now emphasizes clinical trial opportunities for novel agents with considerable promise. ...
thyroidcancer. This reduction was greater for hereditary medullarythyroidcancer (from 27 to 11 mm; ...thyroidcancer. The reduction of medullarythyroidcancers affected exclusively patients with hereditary disease (from 20 to 7 mm; ...
10) and based on small numbers suggestively predicted follicularthyroidcancers (RR = 1.49; ...thyroidcancers. Based on only 15 cases adiposity was unrelated to medullarythyroidcancers. Physical activity was unrelated ...
Risk estimates of first primary differentiatedthyroidcancer (n = 317) were computed using Cox ... 35-40 was significantly associated with an increased risk of differentiatedthyroidcancer when compared with a lean one while earlier body ...
(pro-)cathepsin-L as a target of INSL3 in human thyroidcancer cells facilitating penetration of tumor cells through elastin matrices. ... Recombinant and secreted INSL3 increased the motility of thyroidcarcinoma (TC) cells in an autocrine/paracrine manner. ...
